Independent US Healthcare Provider Directory & Public Medical Database Patient Guides

Dr. Samuel E Myrick , MD

Internal Medicine • Ocala, FL

Active NPI 1831180546 Individual Practitioner Male Practitioner Accepts Medicare assignment
Practice location in NPPES

3130 Sw 32nd Ave
Ocala, FL 344744445

Call 3527324032 Location details and other listings
Medical Disclaimer

This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.

Practice Location & Contact Primary Location

Practice Address

3130 Sw 32nd Ave

Ocala, FL 344744445

Telephone 3527324032
Fax 3527324191
Organization at the Same NPPES Address or Phone
Ocala Oncology Center Pl Facility NPI 1356300958

Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.

Other Listings in Public Data

CMS Doctors and Clinicians lists 2 distinct group names: Cora Health Services Inc; Ocala Oncology Center Pl. See the list

Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.

Listings do not confirm current availability, employment or a shared ownership network.

Medicare Profile & Education

Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026

Medical School

University Of Florida College Of Medicine

Graduation Year

1994

Medicare patients

727 people with Original Medicare in 2024

Different Original Medicare patients in 2024; counts below 11 are hidden; this does not show availability or quality.

Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.

Medicare-allowed amount

About $1,533,766 in 2024

The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.

What this does not show: Medicare-allowed amount

This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.

Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.

Paid by Medicare

About $1,226,575 in 2024

The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.

What this does not show: Paid by Medicare

This is not the clinician's income and not a measure of quality.

Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.

30-day fills

1,158 standardized 30-day fills in 2024

CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.

What this does not show: 30-day fills

It is not a count of patients and not a measure of quality.

Part D drug cost

$1,451,281 in 2024

The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.

What this does not show: Part D drug cost

A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.

Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.

Open Payments general payments, program year 2025

All general payments: $4,616.36 across 203 records.

By nature of payment

  • Food and Beverage: $4,433.08 across 201 records.
  • Education: $99.95 across 1 record.
  • Long term medical supply or device loan: $83.33 across 1 record.

Reporting-company totals (3 largest of 50)

  • Novartis Pharmaceuticals Corporation: $531.86 across 28 records.
  • Bristol Myers Squibb Company: $424.36 across 17 records.
  • AstraZeneca Pharmaceuticals LP: $305.86 across 11 records.

A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.

See the full table

Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).

Guide: How to read an Open Payments record

Years since graduation

32 years (graduated 1994)

CMS Doctors and Clinicians data list 1994 as the year this clinician finished professional school.

What this does not show: Years since graduation

It is not the number of years in practice, and more years does not mean better care.

Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.

NPI first issued

2005

The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.

What this does not show: NPI first issued

NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.

Source: CMS NPPES NPI Registry.

Accepts Medicare assignment

CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.

Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.

Source: CMS Doctors and Clinicians, CMS release of October 2, 2026; Medicare.gov, “Does your provider accept Medicare as full payment?”

Guide: What Medicare assignment means

No telehealth indicator

CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.

Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians, CMS release of October 2, 2026.

Guide: How Medicare covers telehealth

Enrolled in Medicare (PECOS)

Dr. Myrick has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.

It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.

Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.

Guide: What Medicare enrollment (PECOS) means

Can order Medicare-covered services

CMS lists Dr. Myrick as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.

What this does not show: Can order Medicare-covered services

It does not mean the clinician offers these services directly.

Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.

Guide: What ordering and referring status means

Compared with the same specialty in Ocala and Florida

Billing and prescribing volume is not a quality rating.

Medicare Part B services

More Medicare Part B services than 95% of clinicians listed under Internal Medicine in Ocala, FL (2024, 68 clinicians with data). Median for this group: 832. Middle half: 521 to 2,314.

More Medicare Part B services than 95% of clinicians listed under Internal Medicine in Florida (2024, 5,821 clinicians with data). Median for this group: 689. Middle half: 278 to 1,488.

Medicare-allowed amount

A higher Medicare-allowed amount than 95% of clinicians listed under Internal Medicine in Ocala, FL (2024, 68 clinicians with data). Median for this group: $81,972. Middle half: $51,959 to $202,739.

A higher Medicare-allowed amount than 95% of clinicians listed under Internal Medicine in Florida (2024, 5,821 clinicians with data). Median for this group: $68,400. Middle half: $27,804 to $138,071.

Paid by Medicare

A higher Medicare payment amount than 95% of clinicians listed under Internal Medicine in Ocala, FL (2024, 68 clinicians with data). Median for this group: $64,886. Middle half: $36,830 to $156,390.

A higher Medicare payment amount than 95% of clinicians listed under Internal Medicine in Florida (2024, 5,821 clinicians with data). Median for this group: $52,790. Middle half: $20,913 to $107,263.

Medicare Part D prescriptions

Close to the middle for clinicians listed under Internal Medicine in Ocala, FL (2024, 78 clinicians with data). Median for this group: 1,280. Middle half: 161 to 7,057.

Close to the middle for clinicians listed under Internal Medicine in Florida (2024, 6,598 clinicians with data). Median for this group: 1,264. Middle half: 150 to 5,826.

Part D drug cost

A higher Part D drug cost than 95% of clinicians listed under Internal Medicine in Ocala, FL (2024, 78 clinicians with data). Median for this group: $91,088. Middle half: $6,831 to $571,471.

A higher Part D drug cost than 95% of clinicians listed under Internal Medicine in Florida (2024, 6,598 clinicians with data). Median for this group: $82,811. Middle half: $7,744 to $429,824.

106 active clinicians are listed under Internal Medicine with a practice address in Ocala, FL (10,334 in Florida).

Addresses are self-reported to NPPES and may be out of date.

Telehealth indicator in Ocala

17% of these 106 clinicians have the CMS telehealth indicator.

70.8% of these 106 clinicians are listed by CMS as accepting Medicare assignment.

Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS release of October 2, 2026, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.

Text: T-MedInfo · Report an error.

Pharma & Medical Device Financial Disclosures

Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments

Open Payments · Program Year 2025
Disclosure Year:

Program year 2025 (payments made January 1 – December 31, 2025): 203 records totaling $4,616.36.

Manufacturer Payment Nature Product Type Amount ($)
Caris MPI, Inc.
Food and Beverage
In-kind items and services
MI CANCER SEEK General $130.89
Genmab U.S., Inc.
Food and Beverage
In-kind items and services
Epkinly General $125.00
Bristol Myers Squibb Company
Food and Beverage
Cash or cash equivalent
REBLOZYL General $116.10
Menarini Silicon Biosystems, Inc.
Food and Beverage
Cash or cash equivalent
Cellsearch General $102.00
Pfizer Inc.
Education
In-kind items and services
— General $99.95
Novartis Pharmaceuticals Corporation
Long term medical supply or device loan
In-kind items and services
KISQALI General $83.33
AstraZeneca Pharmaceuticals LP
Food and Beverage
In-kind items and services
— General $59.51
SUN PHARMACEUTICAL INDUSTRIES INC.
Food and Beverage
In-kind items and services
YONSA General $39.58
Dendreon Pharmaceuticals LLC
Food and Beverage
In-kind items and services
PROVENGE General $34.90
Janssen Pharmaceuticals, Inc
Food and Beverage
In-kind items and services
ERLEADA General $34.60
Regeneron Pharmaceuticals, Inc.
Food and Beverage
In-kind items and services
LIBTAYO General $33.65
Dendreon Pharmaceuticals LLC
Food and Beverage
In-kind items and services
PROVENGE General $33.45
JAZZ PHARMACEUTICALS INC.
Food and Beverage
In-kind items and services
ZEPZELCA General $33.22
AstraZeneca Pharmaceuticals LP
Food and Beverage
In-kind items and services
ENHERTU General $33.19
SUN PHARMACEUTICAL INDUSTRIES INC.
Food and Beverage
In-kind items and services
Odomzo General $32.49
AstraZeneca Pharmaceuticals LP
Food and Beverage
In-kind items and services
— General $32.08
Bristol Myers Squibb Company
Food and Beverage
Cash or cash equivalent
REBLOZYL General $31.79
Regeneron Pharmaceuticals, Inc.
Food and Beverage
In-kind items and services
LIBTAYO General $31.43
Eli Lilly and Company
Food and Beverage
In-kind items and services
VERZENIO General $31.20
Novartis Pharmaceuticals Corporation
Food and Beverage
In-kind items and services
Fabhalta General $30.19
Novartis Pharmaceuticals Corporation
Food and Beverage
In-kind items and services
KISQALI General $30.11
Genmab U.S., Inc.
Food and Beverage
In-kind items and services
Epkinly General $29.48
Bristol Myers Squibb Company
Food and Beverage
Cash or cash equivalent
REBLOZYL General $29.31
Merck Sharp & Dohme LLC
Food and Beverage
In-kind items and services
KEYTRUDA General $29.23
Immunocore Limited
Food and Beverage
In-kind items and services
KIMMTRAK General $29.19

(top 25 shown)

Source: CMS Open Payments, program year 2025, released June 30, 2026.

Performed Procedures & Service Volume

Services billed to Original Medicare Part B in 2024.

CMS Part B · Data Year 2024
Reporting Year:

CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.

HCPCS Code Services Patients Submitted Charge Medicare Allowed
Q5101 Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram
33,420 25 $2.00 $0.33
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use)
19,840 45 $21.00 $2.96
J9271 Injection, pembrolizumab, 1 mg
11,400 20 $152.05 $55.44
J1437 Injection, ferric derisomaltose, 10 mg
9,500 85 $88.32 $19.89
J0897 Injection, denosumab, 1 mg
7,560 69 $77.83 $25.66
J1453 Injection, fosaprepitant, 1 mg
3,900 19 $6.00 $0.14
J1568 Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg
3,230 19 $262.00 $46.44
J1449 Injection, eflapegrastim-xnst, 0.1 mg
2,244 11 $92.00 $25.48
J1100 Injection, dexamethasone sodium phosphate, 1 mg
896 47 $1.00 $0.11
Q5106 Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units
880 14 $30.00 $7.54
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
878 274 $35.00 $7.61
36415 Insertion of needle into vein for collection of blood sample
841 272 $19.00 $8.65
80053 Blood test, comprehensive group of blood chemicals
781 265 $62.00 $10.32
J1626 Injection, granisetron hydrochloride, 100 mcg
560 27 $25.00 $0.32
J2469 Injection, palonosetron hcl, 25 mcg
460 31 $122.00 $0.89
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
436 210 $224.00 $131.15
96372 Injection of drug or substance under skin or into muscle
395 203 $93.00 $14.56
96375 Injection of additional new drug or substance into vein
357 89 $105.00 $15.38
96413 Administration of chemotherapy into vein, 1 hour or less
228 94 $686.00 $127.85
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
200 131 $304.00 $62.54
J9045 Injection, carboplatin, 50 mg
186 14 $300.00 $3.54
83540 Iron level
181 90 $26.00 $6.25
83550 Iron binding capacity
181 90 $34.00 $8.45
83521 Measurement of immunoglobulin light chains
152 51 $60.00 $16.74
J1200 Injection, diphenhydramine hcl, up to 50 mg
132 46 $7.00 $0.81

(top 25 shown)

Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits

Submitted charges are billed amounts, not a price quote for your visit.

Medicare Part D Prescribing Profile & Medications

Medicare Part D prescriptions filled, including refills, in 2024.

CMS Part D · Data Year 2024
Prescription Year:
Brand Name Generic Name Prescriptions Day Supply Total Cost Patients
Anastrozole Anastrozole 129 9,743 $3,488.29 40
Prednisone Prednisone 60 1,941 $214.31 20
Dexamethasone Dexamethasone 58 867 $801.15 24
Abiraterone Acetate Abiraterone Acetate 47 1,410 $41,656.37 —
Tamoxifen Citrate Tamoxifen Citrate 39 2,855 $1,885.06 13
Eliquis Apixaban 36 1,500 $29,162.87 12
Xarelto Rivaroxaban 33 1,510 $27,633.57 —
Letrozole Letrozole 30 1,742 $747.91 12
Gabapentin Gabapentin 26 1,020 $423.70 —
Hydroxyurea Hydroxyurea 25 1,197 $952.26 —
Acyclovir Acyclovir 24 662 $271.36 —
Alendronate Sodium Alendronate Sodium 23 1,258 $64.80 —
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen 22 373 $363.16 —
Imbruvica Ibrutinib 21 588 $337,586.72 —
Erleada Apalutamide 20 780 $372,462.00 —
Potassium Chloride Potassium Chloride 19 459 $95.77 —
Lenalidomide Lenalidomide 19 532 $157,991.99 —
Olanzapine Olanzapine 18 328 $90.26 12
Lidocaine Hcl Viscous Lidocaine Hcl 16 155 $140.84 —
Lorazepam Lorazepam 14 63 $8.86 12
Ondansetron Odt Ondansetron 13 150 $218.51 11
Xtandi Enzalutamide 13 390 $182,919.23 —
Venlafaxine Hcl Er Venlafaxine Hcl 12 360 $32.79 —
Lenvima Lenvatinib Mesylate 12 360 $291,709.30 —
Warfarin Sodium Warfarin Sodium 11 942 $143.50 —

(top 25 shown)

Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits

Specialties & License Numbers Reported to NPPES

Self-certified to NPPES: 2023-02-27
Internal Medicine Primary Specialty

NUCC Taxonomy Code: 207R00000X

License # reported to NPPES FL ME90579

A physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs.

Internal Medicine - Medical Oncology

NUCC Taxonomy Code: 207RX0202X

License # reported to NPPES FL ME90579

An internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer.

Check License Status with the State Board License numbers are self-reported to NPPES; T-MedInfo does not confirm them against state records. Current status: Florida Department of Health Medical Quality Assurance.
Look Up on State Board Site

Additional State Medicaid & Healthcare Payer Identifiers

Medicaid ID
274398100 (FL)
Medicaid ID
522939661A (GA)

Medicare (PECOS) Enrollment & Ordering Eligibility

Source: CMS PECOS
Medicare FFS Enrollment Status Medicare Enrollment on File
CMS Provider Specialty

PRACTITIONER - MEDICAL ONCOLOGY

Medicare Enrollment ID

I20050112000448

Enrollment State Jurisdiction

FL

PECOS Control ID

0941258313

Medicare Order & Referring Eligibility
Clinical Lab & Imaging (Part B) Eligible
Durable Medical Equipment (DME) Eligible
Home Health Agency (HHA) Eligible
Power Mobility Devices (PMD) Eligible

Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.

Medicare Group Practice Enrollments

Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026

Cora Health Services Inc

1050 Old Camp Rd, The Villages, FL 321621762

Phone: 3526933378

Ocala Oncology Center Pl

3130 Sw 32nd Ave, Ocala, FL 344744445

Phone: 3527324032

Clinicians Sharing This Practice Address or Phone

Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.

10 listed
Lilia Aguila , APRN

Nurse Practitioner - Family

NPI 1326698424

Advanced Practice Registered Nurse

Dr. Rama Balaraman , MD

Internal Medicine - Medical Oncology

NPI 1396709424

Doctor of Medicine (M.D.)

Dr. Maury Berger , MD

Internal Medicine - Medical Oncology

NPI 1457310054

Doctor of Medicine (M.D.)

Dr. Ketan Doshi , MD

Internal Medicine - Medical Oncology

NPI 1750573069

Doctor of Medicine (M.D.)

Dally Legaspi , APRN, FNP-C

Nurse Practitioner - Family

NPI 1942849955

Advanced Practice Registered Nurse, Family Nurse Practitioner (Certified)

Lorelly Mobley , NP

Nurse Practitioner - Family

NPI 1598237349

Nurse Practitioner

Career & Practice History Timeline

Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status

8 Historical Events
📍
Updated Business Mailing Address April 16, 2021

Registered at 3130 SW 32ND AVE, OCALA, FL 344744445 (Tel: 3527324032)

📍
Updated Practice Location March 26, 2021

Registered at 3130 SW 32ND AVE, OCALA, FL 344744445 (Tel: 3527324032)

✅
NPI Profile Active October 27, 2015

NPI status registered as active in NPPES database

📍
Practice Location (Initial Record) October 27, 2015

Registered at 433 SW 10TH ST, OCALA, FL 344710209 (Tel: 3527324032)

📍
Business Mailing Address (Initial Record) October 27, 2015

Registered at 433 SW 10TH ST, OCALA, FL 344710209 (Tel: 3527324032)

👤
Provider Name / Credentials (Initial Record) October 27, 2015

Recorded as SAMUEL MYRICK, MD

🎓
Medical Taxonomy / Specialty Registered (Primary Specialty) October 27, 2015

Internal Medicine (license number reported to NPPES: FL ME90579)

🟢
Initial NPI Registration & Enumeration November 02, 2005

First registered as active Individual Practitioner in NPPES Database.

No reviews have been published yet. Leave a review.

NPI Administrative Meta

NPI Number: 1831180546
Entity Type:
Individual Provider Physician, Nurse Practitioner, or Solo Healthcare Professional (Type 1 NPI)
Enumeration Date: November 02, 2005
Last Update: February 27, 2023
Sole Proprietor: No

Other Internal Medicine Providers in Ocala

All Internal Medicine Providers in Ocala

Mailing Address

3130 Sw 32nd Ave

Ocala, FL 344744445

Phone: 3527324032

About This Data NPPES fields (address, phone, specialty, license) are self-reported and may be outdated; Medicare fields follow the CMS dataset named in each section. Correct directly at NPPES.